Why the study?
Does a 4-point scoring system using albumin and creatinine identify patients with liver disease receiving warfarin who are at risk for poor outcomes?
Does a 4-point scoring system using albumin and creatinine identify patients with liver disease receiving warfarin who are at risk for poor outcomes?
A 4-point scoring system using albumin and creatinine can identify patients with liver disease on warfarin who are at high risk for hemorrhages and poor anticoagulation control.
Answers are grounded in this paper and cite their sources.
May aid risk stratification in warfarin-treated liver disease; leaves open prospective validation before practice change.
Patients with liver disease receiving warfarin have poorer anticoagulation control and more hemorrhages. A simple 4-point scoring system using albumin and creatinine identifies those at risk for poor outcomes.
No takes yet. Share an insight, caveat, or question.
Efird et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: